SZodixStudyAcademic Library
ShelvesOpen access
Study · an open academic library·Metadata from OpenAlex (CC0)·Shelves·OpenAlex metadata, de-duplicated
Principles of pharmacoeconomic analysis: the case of pharmacist-led interventions
16 references·0 citing·47 second hop
Principles of pharmacoeconomic analysis: the case of pharmacist-led interventions (2021)Principles of pharmacoeconomic analysis: …Identification, Review, and Use of Health State Utilities in Cost-Effectiveness Models: An ISPOR Good Practices for Outcomes Research Task Force Report (2019)Identification, Review, and U…Application of discrete event simulation in health care: a systematic review (2018)Application of discrete event…A Health Economics Approach to US Value Assessment Frameworks—Summary and Recommendations of the ISPOR Special Task Force Report [7] (2018)A Health Economics Approach t…Country-Level Cost-Effectiveness Thresholds: Initial Estimates and the Need for Further Research (2016)Country-Level Cost-Effectiven…Cost–effectiveness thresholds: pros and cons (2016)Cost–effectiveness thresholds…Systematic overview of cost–effectiveness thresholds in ten countries across four continents (2015)Systematic overview of cost–e…Economic Evaluation Enhances Public Health Decision Making (2015)Economic Evaluation Enhances …Cost-of-Illness Studies: An Updated Review of Current Methods (2015)Cost-of-Illness Studies: An U…Consolidated Health Economic Evaluation Reporting Standards (CHEERS) Statement (2013)Consolidated Health Economic …Consolidated Health Economic Evaluation Reporting Standards (CHEERS) statement (2013)Consolidated Health Economic …Budget Impact Analysis—Principles of Good Practice: Report of the ISPOR 2012 Budget Impact Analysis Good Practice II Task Force (2013)Budget Impact Analysis—Princi…Using Effectiveness and Cost-effectiveness to Make Drug Coverage Decisions (2009)Using Effectiveness and Cost-…Modelling Methods for Pharmacoeconomics and Health Technology Assessment (2008)Modelling Methods for Pharmac…Welfarism vs. extra-welfarism (2007)Welfarism vs. extra-welfarismWillingness to Pay for a QALY (2005)Willingness to Pay for a QALYUtilities and Quality-Adjusted Life Years (1989)Utilities and Quality-Adjuste…Does NICE have a cost‐effectiveness threshold and what other factors influence its decisions? A binary choice analysis (2004)Risk sharing arrangements for pharmaceuticals: potential considerations and recommendations for European payers (2010)Attributes and weights in health care priority setting: A systematic review of what counts and to what extent (2015)Using health technology assessment to assess the value of new medicines: results of a systematic review and expert consultation across eight European countries (2017)Markov Models in Medical Decision Making (1993)Cost-Effectiveness in Health and Medicine (1996)Discrete Event Simulation: The Preferred Technique for Health Economic Evaluations? (2010)The long‐term cost‐effectiveness of obesity prevention interventions: systematic literature review (2012)A review of economic evaluations of behavior change interventions: setting an agenda for research methods and practice (2013)Handbook of Research Methods in Social and Personality Psychology (2014)Crime and Punishment: An Economic Approach (1968)A Treatise on the Family (1991)The Quality of Life (1993)Caring for and caring about: Disentangling the caregiver effect and the family effect (2010)Using Cost-Effectiveness Analysis to Address Health Equity Concerns (2017)A Health Opportunity Cost Threshold for Cost-Effectiveness Analysis in the United States (2020)Decisions with Multiple Objectives: Preferences and Value Tradeoffs. (1994)Multi-Attribute Preference Functions (1995)A Comparative Review of Generic Quality-of-Life Instruments (2000)The Health Utilities Index (HUI®) system for assessing health-related quality of life in clinical studies (2001)Methods for the Economic Evaluation of Health Care Programmes (2005)Theory of games and economic behavior (2019)Consolidated Health Economic Evaluation Reporting Standards (CHEERS)—Explanation and Elaboration: A Report of the ISPOR Health Economic Evaluation Publication Guidelines Good Reporting Practices Task Force (2013)Essential medicines for universal health coverage (2016)Consolidated Health Economic Evaluation Reporting Standards (CHEERS) 2022 Explanation and Elaboration: A Report of the ISPOR CHEERS II Good Practices Task Force (2022)Consolidated Health Economic Evaluation Reporting Standards 2022 (CHEERS 2022) Statement: Updated Reporting Guidance for Health Economic Evaluations (2022)The Value of a Statistical Life: A Critical Review of Market Estimates Throughout the World (2003)Updating Cost-Effectiveness — The Curious Resilience of the $50,000-per-QALY Threshold (2014)The International Decision Support Initiative Reference Case for Economic Evaluation: An Aid to Thought (2016)The Lancet NCDI Poverty Commission: bridging a gap in universal health coverage for the poorest billion (2020)Determining the efficiency path to universal health coverage: cost-effectiveness thresholds for 174 countries based on growth in life expectancy and health expenditures (2023)Global health 2035: a world converging within a generation (2013)Thresholds for the cost–effectiveness of interventions: alternative approaches (2014)Methods for the estimation of the National Institute for Health and Care Excellence cost-effectiveness threshold (2015)Cost-Effectiveness Thresholds: the Past, the Present and the Future (2018)An Introduction to the Main Types of Economic Evaluations Used for Informing Priority Setting and Resource Allocation in Healthcare: Key Features, Uses, and Limitations (2021)Quantifying the global burden of mental disorders and their economic value (2022)Computer simulation in management science (1984)A taxonomy of model structures for economic evaluation of health technologies (2006)Discrete event simulation for performance modelling in health care: a review of the literature (2010)Mathematical modelling for health systems research: a systematic review of system dynamics and agent-based models (2019)A System Dynamics Simulation Applied to Healthcare: A Systematic Review (2020)Discrete-Event Simulation Modeling in Healthcare: A Comprehensive Review (2021)Cost-Effectiveness Analysis Alongside Clinical Trials II—An ISPOR Good Research Practices Task Force Report (2015)How to prepare a systematic review of economic evaluations for informing evidence-based healthcare decisions: a five-step approach (part 1/3) (2016)Exploratory Research (2020)Cost-effectiveness of Atezolizumab Plus Bevacizumab vs Sorafenib as First-Line Treatment of Unresectable Hepatocellular Carcinoma (2021)
this work references cited by second hop

References

  • 2013Consolidated Health Economic Evaluation Reporting Standards (CHEERS) statement1,776 cited
  • 2013Budget Impact Analysis—Principles of Good Practice: Report of the ISPOR 2012 Budget Impact Analysis Good Practice II Task Force1,177 cited
  • 2016Country-Level Cost-Effectiveness Thresholds: Initial Estimates and the Need for Further Research889 cited
  • 1989Utilities and Quality-Adjusted Life Years819 cited
  • 2016Cost–effectiveness thresholds: pros and cons789 cited
  • 2013Consolidated Health Economic Evaluation Reporting Standards (CHEERS) Statement657 cited
  • 2009Using Effectiveness and Cost-effectiveness to Make Drug Coverage Decisions343 cited
  • 2007Welfarism vs. extra-welfarism333 cited
  • 2018Application of discrete event simulation in health care: a systematic review251 cited
  • 2008Modelling Methods for Pharmacoeconomics and Health Technology Assessment171 cited
  • 2019Identification, Review, and Use of Health State Utilities in Cost-Effectiveness Models: An ISPOR Good Practices for Outcomes Research Task Force Report166 cited
  • 2015Systematic overview of cost–effectiveness thresholds in ten countries across four continents154 cited
  • 2018A Health Economics Approach to US Value Assessment Frameworks—Summary and Recommendations of the ISPOR Special Task Force Report [7]152 cited
  • 2015Economic Evaluation Enhances Public Health Decision Making

Only edges whose both ends are imported exist here. Widen the year window, or show the whole map. Back to the work

126 cited
  • 2005Willingness to Pay for a QALY113 cited
  • 2015Cost-of-Illness Studies: An Updated Review of Current Methods112 cited
  • Cited by

    No citing works inside the corpus for this window.